Intelligence · Clinical Development
Pipeline search results
Programs matching “qing” across our ClinicalTrials.gov index — phase, modality, sponsor, and trial IDs.
Quick answer
Showing 138 pipeline programs matching "qing" from NovaPharmaNews Clinical Development Intelligence — phase, modality, sponsor, and ClinicalTrials.gov trial IDs.
Refine search
Search results
-
100 mg PRAX-944
Chongqing Precision Biotech Co., Ltd
Essential Tremor
1 trial -
30mg PRAX-628
Chongqing Precision Biotech Co., Ltd
Focal Onset Seizure
1 trial -
60 mg PRAX-114 or 40 mg PRAX-114
Chongqing Precision Biotech Co., Ltd
Post-traumatic Stress Disorder
1 trial -
Atorvastatin Oral Tablet
Chongqing Precision Biotech Co., Ltd
Mild Cognitive Impairment
1 trial -
BCMA CAR-T cells
Chongqing Precision Biotech Co., Ltd
Multiple Myeloma
2 trials -
BCMA targeted prime CAR-T cells
Chongqing Precision Biotech Co., Ltd
Multiple Myeloma
1 trial -
CD123 CAR-T cells
Chongqing Precision Biotech Co., Ltd
Leukemia
2 trials -
CD123 targeted CAR-NK cells
Chongqing Precision Biotech Co., Ltd
Acute Myeloid Leukemia
1 trial -
CD19 CAR-T cells
Chongqing Precision Biotech Co., Ltd
Autoimmune Diseases
1 trial -
CD19 CAR-T cells
Chongqing Precision Biotech Co., Ltd
Leukemia
2 trials -
CD19 and CD22 targeted CAR-T cells
Chongqing Precision Biotech Co., Ltd
Leukemia, B-cell
2 trials -
CD19 and CD22 targeted prime CAR- T cells
Chongqing Precision Biotech Co., Ltd
B Cell Lymphoma
1 trial -
CD19 and CD22 targeted prime CAR-T cells
Chongqing Precision Biotech Co., Ltd
B-ALL
1 trial -
CEA CAR-T cells
Chongqing Precision Biotech Co., Ltd
Solid Tumor
1 trial -
CEA-targeted CAR-T cells
Chongqing Precision Biotech Co., Ltd
Gastric Cancer
3 trials -
Gemcitabine
Chongqing Precision Biotech Co., Ltd
Pancreatic Cancer, Adult
1 trial -
Lifei Qingchang Granules
The First People's Hospital of Lianyungang
Bronchiectasis
1 trial -
Melphalan flufenamide (Melflufen)
Chongqing Precision Biotech Co., Ltd
Multiple Myeloma
1 trial -
NEO-201 in combination with pembrolizumab
Chongqing Precision Biotech Co., Ltd
Non Small Cell Lung Cancer
1 trial -
NPC-1C/NEO-102
Chongqing Precision Biotech Co., Ltd
Metastatic Pancreatic Cancer
1 trial -
NY-ESO-1(TCR Affinity Enhancing Specific T cell Therapy)
Chongqing Precision Biotech Co., Ltd
Soft Tissue Sarcoma
1 trial -
OPM-101
Chongqing Precision Biotech Co., Ltd
Advanced Melanoma
1 trial -
PBCAR20A
Chongqing Precision Biotech Co., Ltd
Non-Hodgkin's Lymphoma, Relapsed
1 trial -
PBGENE-DMD (IV)
Chongqing Precision Biotech Co., Ltd
Duchenne Muscular Dystrophy With Mutations Amenable to PBGENE-DMD
1 trial
Frequently asked questions
What is the Clinical Development Intelligence Platform?
It is NovaPharmaNews pipeline intelligence hub covering 20,548 clinical development programs — not just a directory. It includes phase distribution dashboards, therapeutic area overviews, NDA/BLA watchlists, upcoming readouts, company pipeline rankings, competitive landscape maps, and personalized watchlists.
How does this compare to Evaluate Pharma or Citeline?
Like Evaluate Pharma and Citeline Trialtrove, we index ClinicalTrials.gov programs by sponsor, phase, and indication. Our platform adds cross-links to NovaPharmaNews company profiles, drug INN pages, patents, and congress readout calendars — improving crawl depth and reducing orphan program pages.
Where does pipeline data come from?
Program records derive from ClinicalTrials.gov and link to sponsor company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment decisions. See our data sources page for attribution.
Can I follow a company or program for updates?
Yes — use the watchlist forms on this page to follow sponsors, individual programs, disease clusters, or therapeutic areas. Alerts use the same subscription infrastructure as our events intelligence hub.